3B Future Health Fund II S.C.A. SICAV-RAIF is a Luxembourg based investment fund with focus on early-stage investment opportunities in Europe and the U.S in areas of high unmet patient need, mainly oncology and rare disease therapeutics.

The Fund is the second investment fund sponsored by Riccardo Braglia, Group Vice-Chairman and Board Member of 3B Future Holding SA, Switzerland (formerly Helsinn Holding Group) and Chairman and General Partner of 3B Future Health Fund I and II, Luxembourg.

In 2022, 3B Future Health Fund gave its support to Domain Therapeutics and invested in the group to support its advancement to the clinic stage.